In the LY2 HNSCC model, we observed negligible but comparable levels of IFN-γ production in lymph node cells activated by IR HNSCC tumor antigen between tumor-bearing and non-tumor-bearing mice as determined by ELISA, corroborating our flow cytometric findings (Figure 4C). The gene discussed is IFNG; the disease is head and neck squamous cell carcinoma.